For: | Zhao Y, Liu Y, Zhou L, Du GS, He Q. Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(9): 953-966 [PMID: 34621472 DOI: 10.4240/wjgs.v13.i9.953] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i9/953.htm |
Number | Citing Articles |
1 |
Reimi Suzuki, Ryoichi Goto, Norio Kawamura, Masaaki Watanabe, Yoshikazu Ganchiku, Kanako C Hatanaka, Yutaka Hatanaka, Toshiya Kamiyama, Tsuyoshi Shimamura, Akinobu Taketomi. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation. Clinical Journal of Gastroenterology 2022; 15(4): 755 doi: 10.1007/s12328-022-01643-3
|
2 |
Faiza Ahmed, Faiza Zakaria, Godsgift Enebong Nya, Mohamad Mouchli. Sirolimus <i>vs</i> tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?. World Journal of Gastrointestinal Surgery 2022; 14(8): 862-866 doi: 10.4240/wjgs.v14.i8.862
Abstract(144) |
Core Tip(110) |
Full Article(HTML)(536)
|
Full Article (PDF)-1760K(83)
|
Full Article (Word)-109K(46)
|
Peer-Review Report-460K(19)
|
Answering Reviewers-101K(27)
|
Times Cited (0)
|
Total Visits (1622)
|
Open
|